Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 19, 2005

View Archived Issues

Altastaph reported to shorten hospital stay in adult patients with S. aureus bacteremia

Eszopiclone shows efficacy in insomnia associated with MDD

A specific inhibitor of Akt shows antitumor activity and low toxicity in rodents

Antiinflammatory activity of glabridin in a mouse sepsis model

TRPV1 agonist effective against urinary incontinence in preclinical model

Parenteral glutamine reported to increase hsp70 levels in critically ill patients

Melanocortin-4 receptor antagonist potentially useful for the treatment of cachexia

Similar efficacy found for darbepoetin alfa and epoetin alfa in chemotherapy-induced anemia

Data supports development of iroxanadine for cardiovascular diseases

Arimoclomol shows potential for type 2 diabetes in rat studies

Approvable letter for contrast agent MS-325

CR-001 shows potential as antithrombosis drug

Labopharm's once-daily tramadol approved in France

Alvesco launched in U.K.

Enrollment complete in phase I study of Davanat/5-FU

Two new phase II trials evaluate Discovery's Surfactant Replacement Therapy

Evidence suggests an association between resistin and insulin resistance in humans

New data on the pharmacokinetics and pharmacodynamics of oral insulin spray

Tea flavanoid tested in septic shock model

Novel, broad-spectrum chemokine inhibitor shows good pharmacological profile

AstraZeneca patent discloses delta-opioid agonists for pain

Scientists at CSIC report calpain inhibitors

Novel antimitotic compounds in early development at Cytokinetics

Antiinfective agents claimed by Dr. Reddy's

New compositions for cancer diagnosis and therapy

University of Pennsylvania scientists patent new methods for the treatment of cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...